Health & Safety Industry Today

Fluoroscopy and C-Arms Market Targets US$ 4.95 Billion by 2031 with 5.2% CAGR Amid Technological Advancements

The fluoroscopy and C-arms market is expanding steadily, projected to reach US$ 4.95 billion by 2031. Driven by innovations in mobile imaging, AI integration, and low-dose technologies, the market serves key segments like mobile C-arms, image-guided biopsies, angiography, and end users in hospitals and diagnostic centers. Global leaders including GE Healthcare, Siemens, and Philips advance procedural efficiency amid rising minimally invasive surgery demands, with North America leading and Asia-Pacific growing fastest.
Published 15 December 2025

United States of America – December 15, 2025 – According to The Insight Partners, The Fluoroscopy and C Arms Market size is expected to reach US$ 4.95 Billion by 2031. The market is anticipated to register a CAGR of 5.2% during 2025-2031. The fluoroscopy and C-arms market continue to evolve rapidly, driven by advancements in real-time imaging technologies that empower surgeons with precise guidance during complex interventions. Healthcare providers worldwide increasingly rely on these essential tools for procedures like image-guided biopsies, angiography, and discography, enhancing patient outcomes in hospitals, diagnostic centers, and specialty clinics. Recent developments from key players underscore a commitment to portability, dose reduction, and AI integration, positioning the fluoroscopy and C-arms market as a cornerstone of modern medical imaging.​

Check valuable insights in the Fluoroscopy And C-Arms Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPRE00003735/

Market Size, Share, Trends, Analysis, and Forecast by 2031

  • Global Market Size and Growth: The fluoroscopy and C-arms market is projected to reach US$ 4.95 billion by 2031, reflecting steady expansion fueled by demand for mobile imaging solutions across diverse applications.​
  • Market Share by Product: Mobile C-arms dominate due to their flexibility in surgical settings, while full-size and mini-size C-arms capture significant shares in high-volume hospitals and outpatient facilities.​
  • Key Trends: Integration of flat panel detectors and AI-driven automation improves image clarity and reduces radiation exposure, with a shift toward fully motorized systems for enhanced versatility.​
  • Market Analysis: Rising chronic disease prevalence, including cardiovascular and orthopedic conditions, boosts adoption, particularly in cardiology applications that lead procedural volumes.​
  • Forecast to 2031: Growth accelerates through 2031, supported by minimally invasive surgery trends and technological upgrades like 3D reconstruction capabilities.​

Global and Regional Analysis

North America Leadership

North America holds the largest share in the fluoroscopy and C-arms market, driven by advanced healthcare infrastructure and rapid uptake of innovations like low-dose imaging. The U.S. exemplifies this dominance, with high investments in procedural precision for orthopedics and cardiology.​

Europe's Steady Expansion

Europe focuses on patient safety and dose optimization, with Germany and the U.K. leading through stringent standards and NHS modernizations that favor advanced C-arms.​

Asia-Pacific Fastest Growth

Asia-Pacific emerges as the quickest-growing region, propelled by healthcare investments in China, India, and Japan, alongside medical tourism and infrastructure upgrades.​

Other Regions

Latin America, including Brazil, sees gains from public health programs enhancing diagnostic access, while emerging markets prioritize affordable mobile units.​

Updated Market News and Innovations

Recent launches highlight the fluoroscopy and C-arms market's dynamism. In November 2024, GE HealthCare introduced "Lung Suite" enhancements for its OEC 3D C-arm, streamlining interventional pulmonology workflows. Siemens Healthineers gained FDA clearance in March 2024 for the CIARTIC Move, the first self-driving mobile C-arm that cuts spine procedure times by up to 50%. Philips unveiled the Zenition 90 Motorized in February 2024 at ECR, featuring table-side controls for vascular and pain management cases. Ziehm Imaging expanded its Ziehm Solo FD line in November 2023 for compact environments, emphasizing space-efficient designs. These updates reflect a broader push toward AI automation and hybrid systems, addressing workflow challenges in busy operating rooms.​

Product Segments and Applications

Mobile C-arms lead the fluoroscopy and C-arms market for their portability in trauma and surgical suites, complementing full-size systems in fixed installations. Mini-size variants gain traction in specialty centers for extremity imaging. Applications span image-guided biopsy for precise tissue sampling, angiography for vascular navigation, and discography in pain management, all benefiting from real-time visualization. End users include hospitals handling complex cases, alongside diagnostic and specialty centers favoring compact models for outpatient efficiency.​

Get Premium Research Report of Fluoroscopy And C-Arms Market Size and Growth Report by 2031 at: https://www.theinsightpartners.com/buy/TIPRE00003735

Key Company Profiles and Competitive Landscape

Industry leaders shape the fluoroscopy and C-arms market through relentless innovation. Ziehm Imaging GmbH excels in compact, high-resolution systems for diverse procedures. GE Healthcare advances 3D capabilities for pulmonology and beyond. Siemens Healthcare pioneers’ automation like self-positioning arms. Hitachi, Ltd., and Philips Healthcare emphasize dose reduction and motorized precision. Hologic, Inc., Toshiba Corporation, OrthoScan, Inc., and Koninklijke Philips N.V. round out the field, focusing on flat-panel tech and procedural versatility. Strategic mergers and product expansions intensify competition, prioritizing clinician needs for mobility and clarity.​

Future Outlook and Industry Impact

The fluoroscopy and C-arms market thrive on minimally invasive trends, with AI and low-dose features mitigating radiation concerns while expanding access. As chronic conditions rise globally, these devices will remain vital for timely interventions, fostering better recovery and cost efficiencies. Stakeholders anticipate continued regional investments, ensuring sustained momentum through 2031.​

Related Reports

About The Insight Partners

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch

Other Industry News

Ready to start publishing

Sign Up today!